# The Safety and Efficacy Study of RiaGev in Healthy Adults

> **NCT04483011** · NA · UNKNOWN · sponsor: **Bioenergy Life Science, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Metabolic Syndrome
- Premature Aging

## Interventions

- **DIETARY_SUPPLEMENT:** RiaGev

## Key facts

- **NCT ID:** NCT04483011
- **Lead sponsor:** Bioenergy Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-25
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04483011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04483011, "The Safety and Efficacy Study of RiaGev in Healthy Adults". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04483011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*